Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma.
about
An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of CholangiocarcinomaAntitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinomaA genomic signature approach to rescue ΔF508-cystic fibrosis transmembrane conductance regulator biosynthesis and function.Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma.Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients.Therapeutic potency of heat-shock protein-90 pharmacological inhibitors in the treatment of gastrointestinal cancer, current status and perspectives.Nab-paclitaxel is effective against intrahepatic cholangiocarcinoma via disruption of desmoplastic stroma.Translational Bioinformatics for Cholangiocarcinoma: Opportunities and Challenges.Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy
P2860
Q26784091-39945DF8-34CA-4532-8A5F-686890771ABAQ33757003-5ABF76FE-46A8-4FB1-AC3E-7B880F28425DQ34305593-C8A170AD-A1EE-40A4-8049-9494DDC512F1Q35594611-587C2135-CF57-4019-9EBF-2B89C021C69DQ36414244-1297A966-1289-4740-93D4-CBB437C3614CQ47645620-AD0145AD-E75C-4514-9F1F-442B1F5E3C2AQ47694405-CB8438B4-0A8B-41B2-AC71-F159B44C51C0Q55497250-DF7EE1DD-4368-49F3-B519-A5553A6D7579Q55513254-58C2C1B3-2987-42BB-8879-E22F3D680D03Q57075019-563BF830-C33B-4024-B539-DBB026B52EDC
P2860
Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Gene expression-based chemical ...... c drugs in cholangiocarcinoma.
@en
Gene expression-based chemical ...... c drugs in cholangiocarcinoma.
@nl
type
label
Gene expression-based chemical ...... c drugs in cholangiocarcinoma.
@en
Gene expression-based chemical ...... c drugs in cholangiocarcinoma.
@nl
prefLabel
Gene expression-based chemical ...... c drugs in cholangiocarcinoma.
@en
Gene expression-based chemical ...... c drugs in cholangiocarcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Gene expression-based chemical ...... ic drugs in cholangiocarcinoma
@en
P2093
Cheng-Hwai Tzeng
Chi-Ying F Huang
Chun-Nan Yeh
Ming-Han Chen
Ming-Huang Chen
Peter Mu-Hsin Chang
Shu-Chaou Chao
Tsung-Wen Chen
Wu-Lung R Yang
Ya-Wen Kao
P2860
P304
P356
10.1002/CNCR.27743
P407
P577
2012-07-18T00:00:00Z